CLOV vs NKTR · rev $1.37B vs rev $98.4M
Clover Health Investments Corp (CLOV) versus Nektar Therapeutics (NKTR) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported NKTR revenue for 2024-12-31 was $98.4M. Net income was -$119.0M. Revenue was up 9.2% from 2023-12-31 to 2024-12-31. NKTR currently screens at market cap $307.2M.
CLOV currently screens at market cap $1.55B. NKTR currently screens at market cap $307.2M.
Not investment advice. Open the CLOV and NKTR stock pages for the full models.
Not investment advice.